2,2'-azobis(2-amidinopropane) has been researched along with oxalates in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Park, JW; Yang, JH | 1 |
Park, JE; Park, JW; Yang, ES; Yang, JH | 1 |
2 other study(ies) available for 2,2'-azobis(2-amidinopropane) and oxalates
Article | Year |
---|---|
Oxalomalate, a competitive inhibitor of NADP+-dependent isocitrate dehydrogenase, enhances lipid peroxidation-mediated oxidative damage in U937 cells.
Topics: Amidines; Cells, Cultured; Enzyme Inhibitors; Glutathione; Humans; Isocitrate Dehydrogenase; Lipid Peroxidation; Malondialdehyde; Microscopy, Confocal; NADP; Organophosphorus Compounds; Oxalates; Oxidants; Oxidation-Reduction; Oxidative Stress; Pyrenes; U937 Cells | 2003 |
Oxalomalate, a competitive inhibitor of NADP+ -dependent isocitrate dehydrogenase, regulates lipid peroxidation-mediated apoptosis in U937 cells.
Topics: Amidines; Antioxidants; Apoptosis; Binding, Competitive; Cell Separation; Cytosol; DNA; Flow Cytometry; Glutathione; Humans; Immunoblotting; Isocitrate Dehydrogenase; Lipid Peroxidation; Microscopy, Fluorescence; NADP; Oxalates; Oxidants; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Time Factors; U937 Cells | 2005 |